GW Pharmaceuticals plc

GW Announces UK Launch of World's First Prescription Cannabis Medicine

Porton Down, England, June 21, 2010 (ots/PRNewswire) - GW Pharmaceuticals plc (GWP:AIM) today announces the UK launch of Sativex(R), its Oromucosal Spray for the treatment of spasticity due to Multiple Sclerosis (MS). Sativex(R) is the world's first prescription cannabis medicine and the UK is the first country in the world to grant a full regulatory authorization ...